CervoMed Company Leadership
| CRVO Stock | 4.83 0.04 0.82% |
CervoMed employs about 15 people. The company is managed by 10 executives with a total tenure of roughly 35 years, averaging almost 3.0 years of service per executive, having 1.5 employees per reported executive. Analysis of CervoMed's management performance can provide insight into the firm performance.
CervoMed Management Team Effectiveness
The company has return on total asset (ROA) of (0.4278) % which means that it has lost $0.4278 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7142) %, meaning that it created substantial loss on money invested by shareholders. CervoMed's management efficiency ratios could be used to measure how well CervoMed manages its routine affairs as well as how well it operates its assets and liabilities.CervoMed retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares.
Some institutional investors establish a significant position in stocks such as CervoMed in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of CervoMed, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
CervoMed Workforce Comparison
CervoMed is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 570. CervoMed holds roughly 15.0 in number of employees claiming about 2.63% of equities under Health Care industry.
CervoMed Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific CervoMed insiders, such as employees or executives, is commonly permitted as long as it does not rely on CervoMed's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, CervoMed insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Gregoire Sylvie over six months ago Acquisition by Gregoire Sylvie of 8100 shares of CervoMed at 6.52 subject to Rule 16b-3 | ||
Boger Joshua S over six months ago Acquisition by Boger Joshua S of 5750 shares of CervoMed at 19.01 subject to Rule 16b-3 | ||
Alam John J over six months ago Acquisition by Alam John J of 60000 shares of CervoMed at 2.3 subject to Rule 16b-3 | ||
Poulton Jeffrey V. over a year ago Acquisition by Poulton Jeffrey V. of 5750 shares of CervoMed at 19.01 subject to Rule 16b-3 | ||
Elder William Robert over a year ago Acquisition by Elder William Robert of 1000 shares of CervoMed at 18.16 subject to Rule 16b-3 | ||
Zavrl Frank over a year ago Acquisition by Zavrl Frank of 5750 shares of CervoMed at 19.01 subject to Rule 16b-3 | ||
Boger Joshua S over a year ago Disposition of 495995 shares by Boger Joshua S of CervoMed at 0.001 subject to Rule 16b-3 | ||
John Tanner over a year ago Acquisition by John Tanner of 16000 shares of CervoMed subject to Rule 16b-3 |
CervoMed Notable Stakeholders
A CervoMed stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as CervoMed often face trade-offs trying to please all of them. CervoMed's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting CervoMed's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| John MD | CEO, CoFounder | Profile | |
| Sylvie PharmD | CoFounder Director | Profile | |
| Dr Cobuzzi | Chief Officer | Profile | |
| Mark Rosch | Government Regulatory | Profile | |
| Claudia MD | Senior Science | Profile | |
| John Tanner | Chief Officer | Profile | |
| Matthew Winton | Chief Officer | Profile | |
| Marinus Verwijs | Executive Operations | Profile | |
| William JD | General Secretary | Profile | |
| Kelly MHA | Executive Development | Profile |
About CervoMed Management Performance
The success or failure of an entity such as CervoMed often depends on how effective the management is. CervoMed management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of CervoMed management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the CervoMed management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
CervoMed Workforce Analysis
Traditionally, organizations such as CervoMed use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare CervoMed within its industry.CervoMed Manpower Efficiency
Return on CervoMed Manpower
| Revenue Per Employee | 649.2K | |
| Revenue Per Executive | 973.8K | |
| Net Loss Per Employee | 1.1M | |
| Net Loss Per Executive | 1.6M | |
| Working Capital Per Employee | 2.6M | |
| Working Capital Per Executive | 3.9M |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CervoMed. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. To learn how to invest in CervoMed Stock, please use our How to Invest in CervoMed guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Will Stock sector continue expanding? Could CervoMed diversify its offerings? Factors like these will boost the valuation of CervoMed. Projected growth potential of CervoMed fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every CervoMed data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding CervoMed requires distinguishing between market price and book value, where the latter reflects CervoMed's accounting equity. The concept of intrinsic value - what CervoMed's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push CervoMed's price substantially above or below its fundamental value.
It's important to distinguish between CervoMed's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding CervoMed should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, CervoMed's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.